214 related articles for article (PubMed ID: 28004353)
1. Association of CCND1 Gene c.870G>A Polymorphism with Breast Cancer Risk: A Case-ControlStudy and a Meta-Analysis.
Soleimani Z; Kheirkhah D; Sharif MR; Sharif A; Karimian M; Aftabi Y
Pathol Oncol Res; 2017 Jul; 23(3):621-631. PubMed ID: 28004353
[TBL] [Abstract][Full Text] [Related]
2. Association of cyclin D1 A870G polymorphism with two malignancies: acute lymphoblastic leukemia and breast cancer.
Bedewy AM; Mostafa MH; Saad AA; El-Maghraby SM; Bedewy MM; Hilal AM; Kandil LS
J BUON; 2013; 18(1):227-38. PubMed ID: 23613410
[TBL] [Abstract][Full Text] [Related]
3. The 870G>A polymorphism of the cyclin D1 gene is not associated with breast cancer.
Krippl P; Langsenlehner U; Renner W; Yazdani-Biuki B; Wolf G; Wascher TC; Paulweber B; Weitzer W; Leithner A; Samonigg H
Breast Cancer Res Treat; 2003 Dec; 82(3):165-8. PubMed ID: 14703063
[TBL] [Abstract][Full Text] [Related]
4. AA genotype of cyclin D1 G870A polymorphism increases breast cancer risk: Findings of a case-control study and meta-analysis.
Akhter N; Alzahrani FA; Dar SA; Wahid M; Sattar RSA; Hussain S; Haque S; Ansari SA; Jawed A; Mandal RK; Almalki S; Alharbi RA; Husain SA
J Cell Biochem; 2019 Oct; 120(10):16452-16466. PubMed ID: 31243808
[TBL] [Abstract][Full Text] [Related]
5. CCND1 and CDKN1B polymorphisms and risk of breast cancer.
Canbay E; Eraltan IY; Cercel A; Isbir T; Gazioglu E; Aydogan F; Cacina C; Cengiz A; Ferahman M; Zengin E; Unal H
Anticancer Res; 2010 Jul; 30(7):3093-8. PubMed ID: 20683061
[TBL] [Abstract][Full Text] [Related]
6. Association of cyclin D1 genotype with breast cancer risk and survival.
Shu XO; Moore DB; Cai Q; Cheng J; Wen W; Pierce L; Cai H; Gao YT; Zheng W
Cancer Epidemiol Biomarkers Prev; 2005 Jan; 14(1):91-7. PubMed ID: 15668481
[TBL] [Abstract][Full Text] [Related]
7. Cyclin D1 gene (CCND1) polymorphism and the risk of squamous cell carcinoma of the larynx.
Rydzanicz M; Golusinski P; Mielcarek-Kuchta D; Golusinski W; Szyfter K
Eur Arch Otorhinolaryngol; 2006 Jan; 263(1):43-8. PubMed ID: 16258756
[TBL] [Abstract][Full Text] [Related]
8. Breast cancer and cyclin D1 gene polymorphism in Turkish women.
Yaylim-Eraltan I; Ergen A; Görmüs U; Arikan S; Küçücük S; Sahin O; Yigit N; Yildiz Y; Isbir T
In Vivo; 2009; 23(5):767-72. PubMed ID: 19779113
[TBL] [Abstract][Full Text] [Related]
9. Contribution of cyclin D1 (CCND1) and E-cadherin (CDH1) alterations to colorectal cancer susceptibility: a case-control study.
Govatati S; Singamsetty GK; Nallabelli N; Malempati S; Rao PS; Madamchetty VK; Govatati S; Kanapuram R; Narayana N; Bhanoori M; Kassetty K; Nallanchakravarthula V
Tumour Biol; 2014 Dec; 35(12):12059-67. PubMed ID: 25146682
[TBL] [Abstract][Full Text] [Related]
10. Association between cyclin D1 (CCND1) G870A polymorphism and gastric cancer risk: a meta-analysis.
Zhang Y; Zeng X; Lu H; Ji H; Zhao E; Li Y
Oncotarget; 2016 Oct; 7(40):66109-66118. PubMed ID: 27623072
[TBL] [Abstract][Full Text] [Related]
11. Relationship between cyclin D1 (A870G) gene polymorphism and lung cancer.
Cakina S; Gulyasar T; Ozen A; Sipahi T; Kocak Z; Sener S
Indian J Biochem Biophys; 2013 Jun; 50(3):233-6. PubMed ID: 23898488
[TBL] [Abstract][Full Text] [Related]
12. Tumor susceptibility and prognosis of breast cancer associated with the G870A polymorphism of CCND1.
Yu CP; Yu JC; Sun CA; Tzao C; Ho JY; Yen AM
Breast Cancer Res Treat; 2008 Jan; 107(1):95-102. PubMed ID: 18043898
[TBL] [Abstract][Full Text] [Related]
13. The effect of cyclin D1 (CCND1) G870A-polymorphism on breast cancer risk is modified by oxidative stress among Chinese women in Singapore.
Ceschi M; Sun CL; Van Den Berg D; Koh WP; Yu MC; Probst-Hensch N
Carcinogenesis; 2005 Aug; 26(8):1457-64. PubMed ID: 15845652
[TBL] [Abstract][Full Text] [Related]
14. CCND1 G870A polymorphism and cervical cancer risk: a case-control study and meta-analysis.
Ni J; Wang M; Wang M; Fu S; Zhou D; Zhang Z; Han S
J Cancer Res Clin Oncol; 2011 Mar; 137(3):489-94. PubMed ID: 20473525
[TBL] [Abstract][Full Text] [Related]
15. The significant association of CCND1 genotypes with gastric cancer in Taiwan.
Kuo HW; Huang CY; Fu CK; Liao CH; Hsieh YH; Hsu CM; Tsai CW; Chang WS; Bau DT
Anticancer Res; 2014 Sep; 34(9):4963-8. PubMed ID: 25202078
[TBL] [Abstract][Full Text] [Related]
16. Lack of association between CCND1 G870A polymorphism and the risk of breast and colorectal cancers.
Grieu F; Malaney S; Ward R; Joseph D; Iacopetta B
Anticancer Res; 2003; 23(5b):4257-9. PubMed ID: 14666635
[TBL] [Abstract][Full Text] [Related]
17. Cyclin D1 G870A polymorphism and breast cancer risk: a meta-analysis involving 23,998 subjects.
Yang J; Liu H; Lu S; Gao M; Du Q; Tang SC
Oncol Res; 2011; 19(12):519-25. PubMed ID: 22812184
[TBL] [Abstract][Full Text] [Related]
18. Association between
Thakur N; Kumari S; Mehrotra R
Biosci Rep; 2018 Dec; 38(6):. PubMed ID: 30361291
[No Abstract] [Full Text] [Related]
19. Interaction of CCND1 genotype and smoking habit in Taiwan lung cancer patients.
Hsia TC; Liu CJ; Lin CH; Chang WS; Chu CC; Hang LW; Lee HZ; Lo WC; Bau DT
Anticancer Res; 2011 Oct; 31(10):3601-5. PubMed ID: 21965784
[TBL] [Abstract][Full Text] [Related]
20. Polymorphisms of HER2 Ile655Val and cyclin D1 (CCND1) G870A are not associated with breast cancer risk but polymorphic allele of HER2 is associated with nodal metastases.
Naidu R; Yip CH; Taib NA
Neoplasma; 2008; 55(2):87-95. PubMed ID: 18237245
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]